Shanghai HeartCare Medical Technology Corp Ltd
06609
Company Profile
Business description
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
Contact
No. 356, Zhengbo Road
Floor 1 and 3, Building 38
Pilot Free Trade Zone
Lingang New District
Shanghai
CHNT: +86 2137526556
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
425
Stocks News & Analysis
stocks
Reassuring organic growth for undervalued ASX share
Efficiency gains are starting to make their mark.
stocks
Big IPOs are enticing but are they good investments?
Historically, buzzy debuts have been painful for buyers.
stocks
This defensive ASX listed REIT offers a 5% yield
Solid outlook underpinned by rent uplifts and development pipeline.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,692.80 | 143.80 | -1.63% |
| CAC 40 | 7,927.75 | 152.99 | -1.89% |
| DAX 40 | 24,802.78 | 661.03 | -2.60% |
| Dow JONES (US) | 48,180.15 | 916.91 | -1.87% |
| FTSE 100 | 10,346.34 | 106.34 | -1.02% |
| HKSE | 22,410.80 | 430.82 | -1.89% |
| NASDAQ | 22,646.68 | 1,232.52 | -5.16% |
| Nikkei 225 | 56,436.65 | 3,007.56 | -5.06% |
| NZX 50 Index | 14,107.41 | 139.84 | -0.98% |
| S&P 500 | 6,919.09 | 256.74 | -3.58% |
| S&P/ASX 200 | 8,592.60 | 137.80 | -1.58% |
| SSE Composite Index | 3,533.79 | 43.82 | -1.22% |